$55.14
1.452.7%
Last update: Nov 9, 5:52 PM
Cytokinetics Inc
CYTKNASDAQ
The average analyst price target for Cytokinetics is $100.08, 81.3% above the current price. Of 21 analysts, 20 rate it Buy and 1 Hold. Targets range from $56 to $140. The latest change came on Nov 5, 2026, when Citigroup raised its price target on Cytokinetics from $99 to $105 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 21 Analysts
Rating Trend — Last 9 Months
